A novel marine drug, sz-685c, induces apoptosis of mmq pituitary tumor cells by downregulating mir-200c

Current Medicinal Chemistry

Volumn 20, Issue 16, 2013, Pages 2145-2154

  Chen, C H ^a   Xiao, W W ^a   Jiang, X B ^c   Wang, J W ^c   Mao, Z G ^c   Lei, N ^a   Fan, X ^c   Song, B B ^a   Liao, C X ^c   Wang, H J ^c   She, Z G ^b,c   Zhu, Y H ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Key Laboratory of Functional Molecules from Oceanic Microorganisms   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Mangrove endophytic fungus; Marine drug; MicroRNA; MiR 200c; MMQ cell; Pituitary adenoma; Prolactinoma; SZ 685C; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG METABOLITE; FLUORESCEIN ISOTHIOCYANATE; HOE 33342; LIPOCORTIN 5; MESSENGER RNA; MICRORNA 200C; PROLACTIN; SZ 685C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HYPOPHYSIS ADENOMA; IMMUNOBLOTTING; NICK END LABELING; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DOWN-REGULATION; MICRORNAS; PITUITARY GLAND; PITUITARY NEOPLASMS; RATS;

EID: 84877969779     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320160007     Document Type: Article

References (32)

1. Ezzat, S.; Asa, S. L.; Couldwell, W. T.; Barr, C. E.; Dodge, W. E.; Vance, M. L.; McCutcheon, I. E:.The prevalence of pituitary adenomas: A systematic review. Cancer, 2004, 101, 613-619. (Pubitemid 38970613)
2. Daly, A. F.; Rixhon, M.; Adam, C.; Dempegioti, A.; Tichomirowa, M. A.; Beckers, A. High prevalence of pituitary adenomas: A crosssectional study in the province of liege, belgium. J. Clin. Endocrinol. Metab, 2006, 91, 4769-4775. (Pubitemid 44917305)
3. Asa, S. L.; Ezzat, S. The pathogenesis of pituitary tumors. Annu. Rev. Pathol, 2009, 4, 97-126.
4. Melmed, S. Mechanisms for pituitary tumorigenesis: The plastic pituitary. J. Clin. Invest., 2003, 112, 1603-1618. (Pubitemid 38063716)
5. Mao, Z. G.;Zhu, Y. H.; Tang, H. L.; Wang, D. Y.; Zhou, J.; He, D. S.; Lan, H.; Luo, B. N.; Wang, H. J. Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases shortterm postoperative cure rates: A prospective, randomised trial. Eur. J. Endocrinol, 2010, 162, 661-666.
6. Klibanski, A. Clinical practice. Prolactinomas. N. Engl. J. Med., 2010, 362, 1219-1226.
7. Dos, S. S. C.; Barbosa, F. R.; Lima, G. A.; Warszawski, L.; Fontes, R.; Domingues, R. C.; Gadelha, M. R. Bmi and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists. Obesity. (Silver. Spring)., 2011, 19, 800-805.
8. Hamilton, D. K.; Vance, M. L.; Boulos, P. T.,;Laws, E. R. Surgical outcomes in hyporesponsive prolactinomas: Analysis of patients with resistance or intolerance to dopamine agonists. Pituitary, 2005, 8, 53-60. (Pubitemid 44680086)
9. Xie, G.; Zhu, X,; Li, Q.; Gu, M.; He, Z.; Wu, J.; Li, J.; Lin, Y.; Li, M.; She. Z.; Yuan. J. Sz-685c, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the akt/foxo pathway. Br. J. Pharmacol, 2010, 159, 689-697.
10. Mao, Z. G.; He, D. S.; Zhou, J.; Yao, B.; Xiao, W. W.; Chen, C. H.; Zhu, Y. H.; Wang, H. J. Differential expression of micrornas in gh-secreting pituitary adenomas. Diagn. Pathol., 2010, 5, 79.
11. Lee, J. W.; Park, Y. A.; Choi, J. J.; Lee, Y. Y.; Kim, C. J.; Choi, C.; Kim, T. J.; Lee, N. W.; Kim, B. G.; Bae, D. S. The expression of the mirna-200 family in endometrial endometrioid carcinoma. Gynecol. Oncol, 2011, 120, 56-62.
12. Liu, X. G.; Zhu, W. Y.; Huang, Y. Y.; Ma, L. N.; Zhou, S. Q.; Wang, Y. K.; Zeng, F.; Zhou, J. H.; Zhang, Y. K. High expression of serum mir-21 and tumor mir-200c associated with poor prognosis in patients with lung cancer. Med. Oncol., 2012, 29, 618-626.
13. Miyoshi, T.; Otsuka, F.; Otani, H.; Inagaki, K.; Goto, J.; Yamashita, M.; Ogura, T.; Iwasaki, Y.; Makino, H. Involvement of bone morphogenetic protein-4 in gh regulation by octreotide and bromocriptine in rat pituitary gh3 cells. J. Endocrinol., 2008,197, 159-169. (Pubitemid 351566935)
14. Molinski, T. F.; Dalisay, D. S.; Lievens, S. L.; Saludes, J. P. Drug development from marine natural products. Nat. Rev. Drug. Discov, 2009, 8, 69-85.
15. Provencio, M.; Sanchez, A.; Gasent, J.; Gomez, P.; Rosell, R. Cancer treatments: Can we find treasures at the bottom of the sea? Clin. Lung. Cancer, 2009, 10, 295-300.
16. Kanai, Y.; Ishiyama, D.; Senda, H.; Iwatani, W.; Takahashi, H.; Konno, H.; Tokumasu, S.; Kanazawa, S. Novel human topoisomerase i inhibitors, topopyrones a, b, c and d. I. Producing strain, fermentation, isolation, physico-chemical properties and biological activity. J. Antibiot. (Tokyo), 2000, 53, 863-872.
17. Kang, L.; Cai, M.; Yu, C.; Zhang, Y.; Zhou, X. Improved production of the anticancer compound 1403c by glucose pulse feeding of marine halorosellinia sp. (No. 1403) in submerged culture. Bioresour. Technol, 2011, 102, 10750-10753.
18. Melmed, S. Pathogenesis of pituitary tumors. Nat. Rev. Endocrinol, 2011, 7, 257-266.
19. Chesnokova, V.; Zonis, S.; Ben-Shlomo, A.; Wawrowsky, K.; Melmed, S. Molecular mechanisms of pituitary adenoma senescence. Front. Horm. Res, 2010, 38, 7-14.
20. Stefaneanu, L.; Kovacs, K.; Scheithauer, B. W.; Kontogeorgos, G.; Riehle, D. L.; Sebo, T. J.; Murray, D.; Vidal, S.; Tran, A.; Buchfelder, M.; Fahlbusch, R. Effect of dopamine agonists on lactotroph adenomas of the human pituitary. Endocr. Pathol, 2000, 11, 341-352. (Pubitemid 32436869)
21. He, L.; Hannon, G. J. Micrornas: Small rnas with a big role in gene regulation. Nat. Rev. Genet, 2004, 5, 522-531. (Pubitemid 38868508)
22. Palmieri, D.; D'Angelo, D.; Valentino, T.; De Martino, I.; Ferraro, A.; Wierinckx, A.; Fedele, M.; Trouillas, J.; Fusco, A. Downregulation of hmga-targeting micrornas has a critical role in human pituitary tumorigenesis. Oncogene, 2012, 31, 3857-3865.
23. D'Angelo, D.; Palmieri, D.; Mussnich, P.; Roche, M.; Wierinckx, A.; Raverot, G.; Fedele, M.; Croce, C. M.; Trouillas, J.; Fusco, A. Altered microrna expression profile in human pituitary gh adenomas: Down-regulation of mirna targeting hmga1, hmga2, and e2f1. J. Clin. Endocrinol. Metab, 2012, 97, E1128-E1138.
24. Xu, Y.; Brenn, T.; Brown, E. R.; Doherty, V.; Melton, D. W. Differential expression of micrornas during melanoma progression: Mir-200c, mir-205 and mir-211 are downregulated in melanoma and act as tumour suppressors. Br. J. Cancer, 2012, 106, 553-561.
25. White, N. M.; Bao, T. T.; Grigull, J.; Youssef, Y. M.; Girgis, A.; Diamandis, M.; Fatoohi, E.; Metias, M.; Honey, R. J.; Stewart, R.; Pace, K. T.; Bjarnason, G. A.; Yousef, G. M. Mirna profiling for clear cell renal cell carcinoma: Biomarker discovery and identification of potential controls and consequences of mirna dysregulation. J. Urol, 2011, 186, 1077-1083.
26. Gottardo, F.; Liu, C. G.; Ferracin, M.; Calin, G. A.; Fassan, M.; Bassi, P.; Sevignani, C.; Byrne, D.; Negrini, M.; Pagano, F.; Gomella, L. G.; Croce, C. M.; Baffa, R. Micro-rna profiling in kidney and bladder cancers. Urol. Oncol, 2007, 25, 387-392. (Pubitemid 47362758)
27. Moustakas, A.; Heldin, C. H. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer. Sci, 2007, 98, 1512-1520. (Pubitemid 47308444)
28. Gregory, P. A.; Bert, A. G.; Paterson, E. L.; Barry, S. C.; Tsykin, A.; Farshid, G.; Vadas, M. A.; Khew-Goodall, Y.; Goodall, G. J. The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting zeb1 and sip1. Nat. Cell. Biol., 2008,10, 593-601. (Pubitemid 351627379)
29. Burk, U.; Schubert, J.; Wellner, U.; Schmalhofer, O.; Vincan, E.; Spaderna, S.; Brabletz, T. A reciprocal repression between zeb1 and members of the mir-200 family promotes emt and invasion in cancer cells. Embo. Rep., 2008, 9, 582-589. (Pubitemid 351772923)
30. Peinado, H.; Olmeda, D.; Cano, A.; Snail, zeb and bhlh factors in tumour progression: An alliance against the epithelial phenotype? Nat. Rev. Cancer., 2007,7, 415-428. (Pubitemid 46809165)
31. Iorio, M. V.; Visone, R.; Di Leva, G.; Donati, V.; Petrocca, F.; Casalini, P.; Taccioli, C.; Volinia, S.; Liu, C. G.; Alder, H.; Calin, G. A.; Menard, S.; Croce, C. M. Microrna signatures in human ovarian cancer. Cancer. Res, 2007, 67, 8699-8707. (Pubitemid 47437445)
32. Park, Y. A.; Lee, J. W.; Choi, J. J.; Jeon, H. K.; Cho, Y.; Choi, C.; Kim, T. J.; Lee, N. W.; Kim, B. G.; Bae, D. S. The interactions between microrna-200c and brd7 in endometrial carcinoma. Gynecol. Oncol, 2012, 124,125-133.